Login Register Cart 0
Generic placeholder image

Current Proteomics

Editor-in-Chief

ISSN (Print): 1570-1646
ISSN (Online): 1875-6247

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Plasma Apolipoprotein-AIV Downregulated in Patients with Major Depressive Disorder having Suicidal Ideation Compared to those without Suicidal Ideation

Author(s): Boby Mathew, Krishnamachari Srinivasan, Johnson Pradeep, Tinku Thomas and Amit Kumar Mandal*

Volume 19, Issue 3, 2022

Published on: 13 January, 2022

Page: [226 - 231] Pages: 6

DOI: 10.2174/1570164618666211104151005

Price: $65

Abstract

Background: Identification of a peripheral biological marker might aid in identifying patients at high risk of attempting suicide and might help in effective early intervention.

Objective: In the present study, we extend the findings of our previous multidimensional proteomics study by examining the levels of plasma Apolipoprotein-AIV in patients diagnosed with major depression with and without suicidal ideation compared to age and gender-matched controls.

Methods: Using the mass spectrometry platform, we quantified the levels of plasma Apolipoprotein- AIV in patients with major depressive disorder with and without suicidal ideation compared to matched controls with isotope-labelled peptides-based quantitative proteomics approach.

Results: The targeted quantitative proteomics approach with isotope-labelled peptides showed that plasma Apolipoprotein-AIV was significantly downregulated in depressed patients having suicidal ideation 1.45 (CI:1.11-1.90) compared to those without suicidal ideation 0.88 (CI:0.77-1.003).

Conclusion: These findings extend our earlier observation of downregulation of plasma Apolipoprotein- AIV in patients with suicidal attempts to depressed patients with suicidal ideation. The consistent downregulation of plasma Apolipoprotein-AIV observed in both the proteomics studies suggests Apolipoprotein-AIV might be a plasma-based biomarker for suicidal behaviour.

Keywords: Apolipoprotein-AIV, plasma proteomics, suicidal ideation, quantitative proteomics, biomarker, endophenotypic.

« Previous Next »
Graphical Abstract

[1]
Patel, V.; Ramasundarahettige, C.; Vijayakumar, L.; Thakur, J.S.; Gajalakshmi, V.; Gururaj, G.; Suraweera, W.; Jha, P. Suicide mortality in India: A nationally representative survey. Lancet, 2012, 379(9834), 2343-2351.
[http://dx.doi.org/10.1016/S0140-6736(12)60606-0] [PMID: 22726517]
[2]
Courtet, P.; Gottesman, I.I.; Jollant, F.; Gould, T.D. The neuroscience of suicidal behaviors: What can we expect from endophenotype strategies? Transl. Psychiatry, 2011, 1(5), e7-e7.
[http://dx.doi.org/10.1038/tp.2011.6] [PMID: 21761009]
[3]
Larkin, C.; Di Blasi, Z.; Arensman, E. Risk factors for repetition of self-harm: A systematic review of prospective hospital-based studies. PLoS One, 2014, 9(1), e84282.
[http://dx.doi.org/10.1371/journal.pone.0084282] [PMID: 24465400]
[4]
Jokinen, J.; Mårtensson, B.; Nordström, A-L.; Nordström, P. CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters? J. Affect. Disord., 2008, 105(1-3), 241-245.
[http://dx.doi.org/10.1016/j.jad.2007.04.008] [PMID: 17499856]
[5]
Nielsen, D.A.; Goldman, D.; Virkkunen, M.; Tokola, R.; Rawlings, R.; Linnoila, M. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch. Gen. Psychiatry, 1994, 51(1), 34-38.
[http://dx.doi.org/10.1001/archpsyc.1994.03950010034005] [PMID: 7506517]
[6]
Mergen, H.; Demirel, B.; Akar, T.; Senol, E. Lack of association between the serotonin transporter and tryptophan hydroxylase gene polymorphisms and completed suicide. Psychiatr. Genet., 2006, 16(2), 53.
[http://dx.doi.org/10.1097/01.ypg.0000199442.75505.f7] [PMID: 16538180]
[7]
Bennett, P.J.; McMahon, W.M.; Watabe, J.; Achilles, J.; Bacon, M.; Coon, H.; Grey, T.; Keller, T.; Tate, D.; Tcaciuc, I.; Workman, J.; Gray, D. Tryptophan hydroxylase polymorphisms in suicide victims. Psychiatr. Genet., 2000, 10(1), 13-17.
[http://dx.doi.org/10.1097/00041444-200010010-00003] [PMID: 10909123]
[8]
Mathew, B.; Srinivasan, K.; Pradeep, J.; Thomas, T.; Murthy, S.K.; Mandal, A.K. Downregulation of apolipoprotein A-IV in plasma & impaired reverse cholesterol transport in individuals with recent acts of deliberate self-harm. Indian J. Med. Res., 2019, 150(4), 365-375.
[http://dx.doi.org/10.4103/ijmr.IJMR_1842_17] [PMID: 31823918]
[9]
Beck, A.T.; Resnik, H.L.P.; Lettieri, D.J. Center for Studies of Suicide Prevention. In: The Prediction of Suicide; Charles Press Publishers, 1974.
[10]
Kliem, S.; Lohmann, A.; Mößle, T.; Brähler, E. German Beck Scale for Suicide Ideation (BSS): Psychometric properties from a representative population survey. BMC Psychiatry, 2017, 17(1), 389.
[http://dx.doi.org/10.1186/s12888-017-1559-9] [PMID: 29202737]
[11]
Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry, 1960, 23, 56-62.
[http://dx.doi.org/10.1136/jnnp.23.1.56] [PMID: 14399272]
[12]
Kessler, R.C.; Andrews, G.; Colpe, L.J.; Hiripi, E.; Mroczek, D.K.; Normand, S.L.T.; Walters, E.E.; Zaslavsky, A.M. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol. Med., 2002, 32(6), 959-976.
[http://dx.doi.org/10.1017/S0033291702006074] [PMID: 12214795]
[13]
Kirkpatrick, D.S.; Gerber, S.A.; Gygi, S.P. The absolute quantification strategy: A general procedure for the quantification of proteins and post-translational modifications. Methods, 2005, 35(3), 265-273.
[http://dx.doi.org/10.1016/j.ymeth.2004.08.018] [PMID: 15722223]
[14]
Kettenbach, A.N.; Rush, J.; Gerber, S.A. Absolute quantification of protein and post-translational modification abundance with stable isotope-labeled synthetic peptides. Nat. Protoc., 2011, 6(2), 175-186.
[http://dx.doi.org/10.1038/nprot.2010.196] [PMID: 21293459]
[15]
Pandey, G.N.; Dwivedi, Y. Peripheral Biomarkers for Suicide. In: The Neurobiological Basis of Suicide; Dwivedi, Y., Ed.; CRC Press/Taylor & Francis: Boca Raton (FL), 2012.
[http://dx.doi.org/10.1201/b12215-21] [PMID: 23035287]
[16]
Mirkovic, B.; Laurent, C.; Podlipski, M.A.; Frebourg, T.; Cohen, D.; Gerardin, P. Genetic association studies of suicidal behavior: A review of the past 10 years, progress, limitations, and future directions. Front. Psychiatry, 2016, 7, 158.
[http://dx.doi.org/10.3389/fpsyt.2016.00158] [PMID: 27721799]
[17]
Yang, Y.; Chen, J.; Liu, C.; Fang, L.; Liu, Z.; Guo, J.; Cheng, K.; Zhou, C.; Zhan, Y.; Melgiri, N.D.; Zhang, L.; Zhong, J.; Chen, J.; Rao, C.; Xie, P. The extrinsic coagulation pathway: A biomarker for suicidal behavior in major depressive disorder. Sci. Rep., 2016, 6(1), 32882.
[http://dx.doi.org/10.1038/srep32882] [PMID: 27605454]
[18]
Steinmetz, A.; Utermann, G. Activation of lecithin: Cholesterol acyltransferase by human apolipoprotein A-IV. J. Biol. Chem., 1985, 260(4), 2258-2264.
[http://dx.doi.org/10.1016/S0021-9258(18)89547-3] [PMID: 3918999]
[19]
Maes, M.; Smith, R.; Christophe, A.; Vandoolaeghe, E.; Van Gastel, A.; Neels, H.; Demedts, P.; Wauters, A.; Meltzer, H.Y. Lower serum High-Density Lipoprotein Cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: Relationship with immune-inflammatory markers. Acta Psychiatr. Scand., 1997, 95(3), 212-221.
[http://dx.doi.org/10.1111/j.1600-0447.1997.tb09622.x] [PMID: 9111854]
[20]
Mathew, B.; Srinivasan, K.; Pradeep, J.; Thomas, T.; Mandal, A.K. Suicidal behaviour is associated with decreased esterified cholesterol in plasma and membrane fluidity of platelets. Asian J. Psychiatr., 2018, 32, 105-109.
[http://dx.doi.org/10.1016/j.ajp.2017.11.023] [PMID: 29222984]
[21]
Daray, F.M.; Grendas, L.N.; Rodante, D.E.; Errasti, A.E.; Cases, G.G.; Moix, C.F.; Uicich, R.E.; Giménez, M.I.; Puppo, S.; Fasolino, G.H.; Portela, A.; Galfalvy, H.C.; Sublette, M.E. Polyunsaturated fatty acids as predictors of future suicide attempt. Prostaglandins Leukot. Essent. Fatty Acids, 2021, 165, 102247.
[http://dx.doi.org/10.1016/j.plefa.2021.102247]

Rights & Permissions Print Cite
Article Metrics
20
1
© 2024 Bentham Science Publishers | Privacy Policy